Gestational trophoblastic neoplasia (GTN), a very hypervascularized tumor, is the most curable gynecologic malignancy ... congested closed cervix, and suspected right adnexal cyst, approximately 10 cm ...

Monitoring blood levels of DNA fragments released by dying tumor cells can accurately predict the return of skin cancer. In a study led by NYU Langone Health and its Perlmutter Cancer Center ...

A study based on long-term follow-up suggests that all patients, irrespective of the method of treatment or the status of their margins, should be monitored closely for tumor recurrence over ...

A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, ...

Nov. 22, 2024 — Researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin ... Study Identifies Subtypes of ...

The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was ...

The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

Several dermoscopic findings may help identify low-grade dysplastic nevi from other lesions, though the performance of the methods used was poor.

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

The approval for use in advanced neuroendocrine tumors is supported by data from the phase 3 CABINET trial (ClinicalTrials.gov Identifier: NCT03375320). The double-blind, placebo-controlled study ...